Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REPLIGEN CORP Director's Dealing 2016

Jun 28, 2016

30826_dirs_2016-06-28_dd541871-deca-4573-a7cb-726bd83aae57.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2016-06-27

Reporting Person: DAWES KAREN A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-06-27 Common Stock M 15000 $3.10 Acquired 57746 Direct
2016-06-27 Common Stock F 1982 $23.46 Disposed 55764 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-06-27 Stock Option (Right to Buy) $3.10 M 15000 Disposed 2016-09-15 Common Stock (15000) Direct

Footnotes

F1: Payment made via forfeiture of 1,982 shares of Common Stock valued at the Closing Price of $23.46 on June 27, 2016.